For women, mammograms are a sometimes uncomfortable, but necessary, annual ritual. But this procedure doesn’t always provide accurate results, and it exposes women to X-rays. In a study appearing in ACS’ journal MolecularPharmaceutics, scientists report that they have developed a non-invasive “disease screening pill” that can make cancerous tumors light up when exposed to near-infrared light in mice without using radiation.
Breast cancer is the second most common cancer in women, according to the American Cancer Society. Mammograms are X-rays of breast tissue that can provide information about a lump’s location and size, but they can’t distinguish between cancerous and benign growths. As a result, up to one in three healthy women undergo unnecessary breast cancer treatments and procedures, according to a recent study by researchers in Denmark. Mammograms also require low levels of radiation. While risk of harm from this exposure is minimal, repeated X-rays can potentially cause health issues. Fluorescent probes can detect breast tumors, but they must be given intravenously. So, Greg M. Thurber and colleagues set out to develop a more accurate, safer technique that was also non-invasive.
The researchers combined two types of molecules into a single pill: a targeting molecule that binds to proteins on the surface of breast cancer cells; and a dye that had negatively charged sulfate groups attached to it. Sulfate groups enhance the solubility of near-infrared florescent dyes, increasing the likelihood of detecting the tumor. Testing in mice showed that with this formulation, a considerable proportion of the imaging agent was absorbed into the bloodstream. It also bound specifically to cancer cells with little background noise. The researchers say that the pill could lead to an accurate, safe and noninvasive way to detect breast cancer, and it could be modified in the future to detect other diseases.
Learn more: Diagnosing breast cancer with an imaging pill
The Latest on: Imaging pill
via Google News
The Latest on: Imaging pill
- ‘Today is day 353’: Woman takes 189 pills a week nearly 1 year after COVID-19 diagnosis to combat symptomson March 3, 2021 at 4:28 pm
March 15 will mark one year since Amy Watson, a preschool teacher from Oregon, first began suffering with COVID-19 symptoms, and she still has a fever. “Today is day 353,” said Watson on March 3.
- Smart Healthcare Products Market to Witness Huge Growth by 2026 | AT&T, Allscripts Healthcare Solutions, Cisco, GE Healthcareon March 3, 2021 at 9:32 am
The research emphasizes elaboration of the Global Smart Healthcare Products market strategy of the industry players in the precision of import/export consumption, supply and demand. The study starts ...
- Clinical Trial Imaging Services Market to Reach $1.80 Bn, Globally, by 2027 at 5.6% CAGR: Allied Market Researchon March 3, 2021 at 5:13 am
Allied Market Research published a report, titled, "Clinical Trial Imaging Services Market by Service Type (Clinical Trial Design & Consultation Services, Reading & Analytical Services, Operational ...
- Ongoing COVID-19 Pandemic Offers Potential Growth Avenues to Dual and Multi-Energy CT Marketon March 2, 2021 at 9:55 pm
Expanding patient pool suffering from cancer, cardiovascular diseases, and dental and orthopedic disorders is primarily driving the need for dual and multi-energy computed tomography (CT) techniques.
- Smart pills and the future of medicine: Insights from your insideson February 23, 2021 at 3:17 am
The first medical pills date from the ancient Egyptians and, apart from the ingredients, not much has changed ever since: you just swallow them and hopefully they're good for what ails you. But now ...
- Madrigal: Leading Biotech In Race For NASH Approval That Nobody Has Been Able To Winon February 16, 2021 at 1:19 pm
Resmetirom - a liver-directed, selective thyroid hormone receptor-ß, ("THR-ß"), agonist in the form of a pill taken once daily ... fat on magnetic resonance imaging-estimated proton density ...
- Butterfly Network Goes Public, Taking Portable Ultrasound Device Globalon February 16, 2021 at 3:02 am
Butterfly has the potential to revolutionize medical imaging by integrating ultrasound ... including wearables, pills and integration with other complementary medical technology.
- “Hot cross bun” is a potential imaging marker for the severity of cerebellar ataxia in MSA-C | npj Parkinson's Diseaseon February 14, 2021 at 4:00 pm
Clinical and imaging characteristics were collected and comparison was performed between MSA-C and MSA-P cases. Spearman test was used to evaluate the correlation between HCBs and other variables.
- Huawei P50 series leak – to use a super imaging systemon February 14, 2021 at 3:57 pm
According to the report, this series will use a new generation super imaging system ... has a center punch-hole camera as against the pill-shaped punch-hole on its predecessor.
via Bing News